November 17, 2017 /

Wave Life Sciences (November 2017)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Wave Life Sciences (November 2017)

PPMD and Wave Life Sciences hosted a webinar on November 14, 2017 to provide an overview of Wave’s stereopure exon skipping oligonucleotide programs for the treatment of Duchenne muscular dystrophy and an introduction to the planned Phase 1 clinical trial.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo